sb 203580 has been researched along with phosphatidylinositol 5-phosphate in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (phosphatidylinositol 5-phosphate) | Trials (phosphatidylinositol 5-phosphate) | Recent Studies (post-2010) (phosphatidylinositol 5-phosphate) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 112 | 0 | 66 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, RA; Boronenkov, IV; Bunce, MW | 1 |
1 other study(ies) available for sb 203580 and phosphatidylinositol 5-phosphate
| Article | Year |
|---|---|
Coordinated activation of the nuclear ubiquitin ligase Cul3-SPOP by the generation of phosphatidylinositol 5-phosphate.
Topics: Active Transport, Cell Nucleus; Cell Cycle Proteins; Cell Line; Cullin Proteins; Enzyme Activation; Humans; Imidazoles; MAP Kinase Kinase 6; Nuclear Proteins; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol Phosphates; Phosphotransferases (Alcohol Group Acceptor); Protein Binding; Protein Kinase Inhibitors; Pyridines; Repressor Proteins; Sensitivity and Specificity; Signal Transduction; Substrate Specificity; Ubiquitination | 2008 |